Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 240

    1.

    Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters.

    van Heek M, Austin TM, Farley C, Cook JA, Tetzloff GG, Davis HR.

    Diabetes. 2001 Jun;50(6):1330-5.PMID: 11375333 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function.

    van Heek M, Farley C, Compton DS, Hoos L, Davis HR.

    Br J Pharmacol. 2001 Sep;134(2):409-17.PMID: 11564660 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.

    Salisbury BG, Davis HR, Burrier RE, Burnett DA, Bowkow G, Caplen MA, Clemmons AL, Compton DS, Hoos LM, McGregor DG, et al.

    Atherosclerosis. 1995 May;115(1):45-63.PMID: 7669087 [PubMed - indexed for MEDLINE]Related articles

    4.

    A high-cholesterol, n-3 polyunsaturated fatty acid diet causes different responses in rats and hamsters.

    Lin MH, Lu SC, Huang PC, Liu YC, Liu SY.

    Ann Nutr Metab. 2005 Nov-Dec;49(6):386-91. Epub 2005 Oct 11.PMID: 16219990 [PubMed - indexed for MEDLINE]Related articles

    5.

    The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys.

    van Heek M, Compton DS, Davis HR.

    Eur J Pharmacol. 2001 Mar 9;415(1):79-84.PMID: 11245855 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins.

    Geiss HC, Otto C, Hund-Wissner E, Parhofer KG.

    Atherosclerosis. 2005 May;180(1):107-12. Epub 2004 Dec 29.PMID: 15823282 [PubMed - indexed for MEDLINE]Related articles

    7.

    Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.

    Zheng S, Hoos L, Cook J, Tetzloff G, Davis H Jr, van Heek M, Hwa JJ.

    Eur J Pharmacol. 2008 Apr 14;584(1):118-24. Epub 2008 Feb 12.PMID: 18329014 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia.

    Lucas CP, Boldrin MN, Reaven GM.

    Am J Cardiol. 2003 Apr 15;91(8):961-4.PMID: 12686336 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.

    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.

    Clin Ther. 2007 Nov;29(11):2419-32.PMID: 18158082 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.

    Knopp RH, Tsunehara C, Retzlaff BM, Fish B, Nguyen H, Anderson S, Nguyen T.

    Metabolism. 2006 Dec;55(12):1697-703.PMID: 17142146 [PubMed - indexed for MEDLINE]Related articles

    11.

    Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia.

    Dujovne CA, Ettinger MP, McNeer JF, Lipka LJ, LeBeaut AP, Suresh R, Yang B, Veltri EP; Ezetimibe Study Group.

    Am J Cardiol. 2002 Nov 15;90(10):1092-7. Erratum in: Am J Cardiol. 2003 Jun 1;91(11):1399. PMID: 12423709 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies.

    Bays HE, Moore PB, Drehobl MA, Rosenblatt S, Toth PD, Dujovne CA, Knopp RH, Lipka LJ, Lebeaut AP, Yang B, Mellars LE, Cuffie-Jackson C, Veltri EP; Ezetimibe Study Group.

    Clin Ther. 2001 Aug;23(8):1209-30. Erratum in: Clin Ther 2001 Sep;23(9):1601. PMID: 11558859 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters.

    Wilson TA, Nicolosi RJ, Woolfrey B, Kritchevsky D.

    J Nutr Biochem. 2007 Feb;18(2):105-12. Epub 2006 May 18.PMID: 16713234 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.

    Kerzner B, Corbelli J, Sharp S, Lipka LJ, Melani L, LeBeaut A, Suresh R, Mukhopadhyay P, Veltri EP; Ezetimibe Study Group.

    Am J Cardiol. 2003 Feb 15;91(4):418-24.PMID: 12586255 [PubMed - indexed for MEDLINE]Related articles

    15.

    Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.

    Davis HR, Veltri EP.

    J Atheroscler Thromb. 2007 Jun;14(3):99-108. Review.PMID: 17587760 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Dietary flaxseed meal is more protective than soy protein concentrate against hypertriglyceridemia and steatosis of the liver in an animal model of obesity.

    Bhathena SJ, Ali AA, Haudenschild C, Latham P, Ranich T, Mohamed AI, Hansen CT, Velasquez MT.

    J Am Coll Nutr. 2003 Apr;22(2):157-64.PMID: 12672712 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Ezetimibe treatment of pediatric patients with hypercholesterolemia.

    Clauss S, Wai KM, Kavey RE, Kuehl K.

    J Pediatr. 2009 Jun;154(6):869-72. Epub 2009 Feb 23.PMID: 19230898 [PubMed - indexed for MEDLINE]Related articles

    18.

    Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.

    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E; Ezetimibe Study Group.

    Am Heart J. 2004 Sep;148(3):447-55.PMID: 15389231 [PubMed - indexed for MEDLINE]Related articles

    19.

    Ezetimibe: a selective cholesterol absorption inhibitor.

    Nutescu EA, Shapiro NL.

    Pharmacotherapy. 2003 Nov;23(11):1463-74. Review.PMID: 14620392 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.

    Tribble DL, Farnier M, Macdonell G, Perevozskaya I, Davies MJ, Gumbiner B, Musliner TA.

    Metabolism. 2008 Jun;57(6):796-801.PMID: 18502262 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data